Sign In
to Vote &
Create Storyboards.
 
Ride Abbott To $100 With Its New COVID-19 Test? Based on historical performance, Abbott Labs (NYSE: ABT) appears to be a better bet compared to Medtronic in the current crisis. The current coronavirus crisis will likely impact medical devices company on two fronts, 1. supply chain disruptions, and 2. decline in number of procedures performed...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard